Schroder Investment Management Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-303,534	Closed	-$783K	–	1423
2017 Q2	$783K	Sell	303,534 -107,762	-26%	-$248K	﹤0.01%	1010
2017 Q1	$888K	Buy	411,296 +279,863	+213%	+$619K	﹤0.01%	969
2016 Q4	$279K	Sell	131,433 -15,848	-11%	-$44.2K	﹤0.01%	1012
2016 Q3	$493K	Sell	147,281 -67,598	-31%	-$215K	﹤0.01%	974
2016 Q2	$675K	Sell	214,879 -52,056	-20%	-$174K	﹤0.01%	947
2016 Q1	$846K	Buy	+266,935	New	+$832K	﹤0.01%	933
2015 Q1	–	Sell	-8,684,695	Closed	-$67M	–	1416
2014 Q4	$67M	Sell	8,684,695 -37,500	-0.4%	-$297K	0.13%	196
2014 Q3	$65.2M	Sell	8,722,195 -6,945	-0.1%	-$64.5K	0.09%	215
2014 Q2	$84.5M	Sell	8,729,140 -67,900	-0.8%	-$605K	0.11%	177
2014 Q1	$73.1M	Buy	8,797,040 +3,675,872	+72%	+$31.5M	0.08%	199
2013 Q4	$43.2M	Buy	5,121,168 +852,600	+20%	+$7.19M	0.05%	286
2013 Q3	$34M	Buy	4,268,568 +805,200	+23%	+$6.47M	0.08%	297
2013 Q2	$26.7M	Buy	+3,463,368	New	+$27M	0.07%	330